Cargando…

Inhibitor of apoptosis proteins as a therapeutic target in breast cancer

Detalles Bibliográficos
Autores principales:	Foster, FM, Bundred, NJ, Streuli, CH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300716/ http://dx.doi.org/10.1186/bcr1897

Ejemplares similares

Inhibitor of apoptosis proteins in breast cancer
por: Foster, FM, et al.
Publicado: (2006)

Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer
por: Foster, Fiona M, et al.
Publicado: (2009)

Impact of full-field digital mammography on diagnostic work-up and surgical management of mammographic microcalcification
por: Bundred, SM, et al.
Publicado: (2012)

Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy
por: Owens, Thomas W, et al.
Publicado: (2013)

Primary ductal carcinoma in situ mammosphere formation: importance of the epidermal growth factor and Notch receptor signalling pathways
por: Farnie, G, et al.
Publicado: (2008)

Bevacizumab resistance in breast cancer: are neuropilins the key?
por: Staton, CA, et al.
Publicado: (2008)

Role of macrophages in breast cancer angiogenesis in vivo
por: Brown, NJ, et al.
Publicado: (2006)

Molecular control of apoptosis in the breast
por: Streuli, C, et al.
Publicado: (2000)

Mitochondrial translocator protein modulates metabolism and pharmacologically induced apoptosis in breast cancer cells
por: Gastaldello, A, et al.
Publicado: (2010)

Effects of recombinant surfactant protein C and elastase inhibitor on neutrophil apoptosis
por: Pravinkumar, E, et al.
Publicado: (2004)

PB.9. Randomised controlled trial of stereotactic 11G vacuum-assisted core biopsy for diagnosis and management of malignant microcalcification
por: Bundred, S, et al.
Publicado: (2014)

Genetic engineering of pharmacologically regulated T cells, specific for breast cancer target antigens
por: Wilkie, S, et al.
Publicado: (2010)

Assessment of apoptosis in human breast tissue using an antibody against the active form of caspase 3: relation to tumour histopathological characteristics
por: Hadjiloucas, I, et al.
Publicado: (2001)

Control of apoptosis in breast by growth factors and extracellular matrix: targets for therapeutic intervention
por: Streuli, C, et al.
Publicado: (2001)

Repeatability of breast density visual assessment
por: Walshaw, L, et al.
Publicado: (2012)

Investigation of the roles of novel apoptosis-controlling genes in breast cancer
por: Williams, GT, et al.
Publicado: (2008)

Current clinical use of the [(18)F]FDG PET/CT in breast cancer patients: an audit of local referral patterns
por: Laurence, NJ, et al.
Publicado: (2010)

Cellular localization of the proto-oncogenic p53 inhibitor AGR2 protein in breast cancer
por: Fourtouna, A, et al.
Publicado: (2008)

Potential use of COX-2–aromatase inhibitor combinations in breast cancer
por: Bundred, N J, et al.
Publicado: (2005)

Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer
por: Sainsbury, R, et al.
Publicado: (2010)

Targeting MICA with therapeutic antibodies for the treatment of cancer
por: Bonnafous, Cécile, et al.
Publicado: (2013)

PB.48: Old habits die hard: breast imaging of symptomatic 35 to 39 year olds
por: Singh, FM, et al.
Publicado: (2013)

Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors
por: Gong, Jian, et al.
Publicado: (2014)

Living with genetic risk of breast cancer: what have we learned?
por: Foster, C
Publicado: (2008)

Role for X-linked Inhibitor of Apoptosis Protein Upstream of Mitochondrial Permeabilization
por: Owens, Thomas W., et al.
Publicado: (2010)

A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
por: Twiddy, D, et al.
Publicado: (2010)

Therapeutic blood purification using functionalized core/shell nanomagnets
por: Herrmann, IK, et al.
Publicado: (2010)

Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence
por: Bluff, JE, et al.
Publicado: (2008)

A pulmonary artery catheter-based treatment algorithm changes therapeutic behaviour in septic patients
por: Bethlehem, C, et al.
Publicado: (2011)

Renal targeted protein therapeutics in experimental overt heart failure with renal dysfunction
por: Chen, Horng H, et al.
Publicado: (2009)

Characterising an aromatase inhibitor resistant breast cancer cell line
por: Harris, E, et al.
Publicado: (2012)

Immunotherapeutic targeting of HSP90 client proteins in BRAF-inhibitor resistant melanoma
por: Fecek, Ronald J, et al.
Publicado: (2015)

A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer
por: Fuller, Steven, et al.
Publicado: (2014)

PB.18: Factors affecting breast density assessment
por: Beattie, L, et al.
Publicado: (2013)

Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer
por: Wolf, Philipp
Publicado: (2023)

Inhibition of apoptosis by Notch signalling in breast epithelial cells
por: Meurette, O, et al.
Publicado: (2008)

P74 Long-term Survival After Minimally Invasive Resection versus Open Pancreaticoduodenectomy for Pancreatic Cancers: A Systematic Review and Meta-analysis
por: Gujjuri, Rohan R, et al.
Publicado: (2021)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Role of CASP8 D302H and other apoptosis gene variants in breast cancer
por: Mistry, SH, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ioo2798du4gmu5dg0iccljbhl9